this effect may counteract the cardiovascular complications by the reduction of the systemic inflammation ( Figure 1 3.2 GLP1-RAs and AMPK GLP-1 (Glucagon-like peptide 1) is an incretin hormone, secreted from L-cells of the small intestine in a glucose-dependent manner, that enables stimulation of insulin secretion, increases pancreatic -cell mass, and inhibits glucagon secretion and gastric emptying, thereby reducing postprandial glycemia
10.1016/j.freeradbiomed.2021.09.006 Free Radic
/ Articles GLP-1s are No Laughing Matter You may have recently heard of some new magic weight loss drugs, Ozempic (semaglutide) and Mounjaro (terzepatide)
If a REMS patent claims a specific method of using the drug that is described in the approved labeling, it may be eligible for listing
Common side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion and heartburn/acid reflux
In patients at higher risk for hypoglycemia and patients who have reduced symptomatic awareness of hypoglycemia, increased frequency of blood glucose monitoring is recommended